Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2411 of 6351
-
Can common painkillers replace opioids after surgery?
Symptom relief Recruiting nowThis trial is being completed to compare two commonly used options to treat pain after surgery. Participants that undergo gallbladder removal, hernia repair, and breast lump removal will be eligible to enroll. Eligible participants will be randomized to 1 of 2 groups of medicatio…
Phase 4 • Sponsor: University of Michigan • Aim: Symptom relief
Last updated Aug 30, 2026 00:00 UTC
-
New glasses could help Kids' eyesight stop getting worse
Disease control OngoingThis is a randomized, controlled, evaluator-blinded, multicenter, two-arm parallel group clinical trial to evaluate the continued safety and efficacy of Diffusion Optics Technology (DOT) spectacle lenses by comparing to single vision, impact-resistant spectacle lenses in reducing…
Sponsor: SightGlass Vision, Inc. • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New hope for chinese HLH patients: emapalumab shows promise
Disease control CompletedThe goal of this post-authorization study is to describe safety and efficacy of emapalumab in treatment experienced Chinese patients with pHLH.
Phase 4 • Sponsor: Swedish Orphan Biovitrum • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Could a natural hormone help restore fertility?
Disease control Recruiting nowThe goal of this study is to see whether kisspeptin, a naturally occurring hormone, can stimulate the release of other reproductive hormones in men and women with idiopathic hypogonadotropic hypogonadism (IHH). The investigators are also examining whether kisspeptin can help wome…
Phase 2 • Sponsor: Stephanie B. Seminara, MD • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Joystick training may help veterans fight alcohol cravings
Disease control Recruiting nowThe proposed study will test a novel treatment for alcohol use disorders (AUD) to determine if it helps Veterans reduce their hazardous drinking and recover from alcohol-related functional impairments across social, occupational, and domestic domains. To do so, the investigators …
Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
New heart failure drug shows promise in Mid-Stage trial
Disease control Stopped earlyThe main purpose of this study is to assess the efficacy and safety of LY3540378 in adults with worsening heart failure with preserved ejection fraction
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Exercise after cancer: could resistance training rebuild bodies?
Disease control Recruiting nowThis protocol seeks to analyze patient outcomes of the standard of care, monitored group exercise regimen of high-load resistance training and functional exercises with compound movements under close supervision on individuals who have been treated for cancer.
Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New heart test could predict sudden cardiac death risk
Diagnosis Recruiting nowCalcium Release Deficiency Syndrome (CRDS) is a novel inherited arrhythmia syndrome secondary to RyR2 loss-of-function that confers a risk of sudden cardiac death. Diagnosis of CRDS presently requires cellular-based in vitro confirmation that an RyR2 variant causes loss-of-functi…
Sponsor: Population Health Research Institute • Aim: Diagnosis
Last updated Jul 24, 2026 00:00 UTC
-
CRISPR Gene-Edited immune cells aim to fight lung cancer – but trial never started
Disease control CancelledA clinical trial to assess the safety and efficacy of genetically-engineered Tumor Infiltrating Lymphocytes (TIL) in which the intracellular immune checkpoint CISH has been inhibited using CRISPR gene editing for the treatment of Metastatic Non-small Cell Lung Cancer (NSCLC).
Phase 1/2 • Sponsor: Intima Bioscience, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Peer support program aims to boost recovery in early psychosis
Disease control OngoingPsychosis is a major disabling and disruptive mental illness characterized by a wide variety of disturbances in cognition and emotions, resulting in poor psychosocial functioning and frequent relapses. Despite convincing evidence of short-term symptom control and functional recov…
Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Can a daily pill prevent dangerous clots after joint surgery?
Disease control CompletedVenous thromboembolism is a serious complication after total hip replacement (THR) and total knee replacement (TKR). Previous studies have reported the incidence of both asymptomatic and symptomatic deep vein thrombosis (DVT) after TKR were higher in Taiwan than other countries i…
Sponsor: Chiayi Christian Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a simple nerve block stop chronic pain after C-Section?
Prevention CompletedThe aim of this study is to compare the incidence of CPSCP in patients receiving QLB quadratus lumborum block and ITM versus control as a primary outcome and associated risk factors that might predispose patients to develop CPSCP.
Sponsor: Menoufia University • Aim: Prevention
Last updated Aug 16, 2026 00:00 UTC
-
A gentle zap on the wrist might quiet chronic nausea
Symptom relief Recruiting nowThe goal of this clinical trial is to learn whether a wearable transcutaneous electrical nerve stimulation (TENS) device called EmeTerm can help reduce nausea in adults who have had nausea for 2 months or longer and who receive care at The Ohio State University. The study will al…
Sponsor: Ohio State University • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
New Stent-Graft shows promise for tough aneurysm cases
Disease control CompletedThe goal of this multicenter, observational cohort study is to evaluates the clinical effectiveness of a single-renal scallop custom-made stent-graft (TREO, Terumo Aortic, Sunrise, FL) to treat "hostile" AAA with mismatched renal arteries as actual standard of care in this Vascul…
Sponsor: Azienda Ospedaliero-Universitaria di Modena • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Custom plastic implants for skull and face defects under scrutiny in new study
Disease control OngoingThe purpose of this study is to confirm the safety, performance and effectiveness of Stryker's PEEK Customized Implants when used for the augmentation and/or restoration of bony and/or soft tissue deformities in the cranial and craniofacial skeleton. The study is designed as a pr…
Sponsor: Stryker Craniomaxillofacial • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New approach to diabetes prevention: let patients set their own goals
Prevention CompletedThis is a cluster-randomized controlled trial of NDPP-Flex versus the standard NDPP to evaluate effects on glycemia, heterogeneity of treatment effects, and mechanisms of change. We will recruit 200 diverse adults with prediabetes (A1C 5.7-6.4%) and normal weight or overweight/ob…
Sponsor: Denver Health and Hospital Authority • Aim: Prevention
Last updated Jun 27, 2026 07:57 UTC
-
Could a common heart drug ease ulcerative colitis?
Disease control CompletedStatins exert numerous pleiotropic effects including anti-inflammatory, antioxidant properties, endothelial function improvement, and immunomodulation independent of their basic lipid-lowering properties.
Phase 2 • Sponsor: Tanta University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Weekly shot may help short kids grow – new study underway
Disease control OngoingThe purpose of this study is to find out if somapacitan is safe and how well somapacitan works in children either born small for gestational age or with Turner syndrome, Noonan syndrome or idiopathic short stature. Somapacitan is a new growth hormone medicine for treatment of low…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New program aims to boost Veterans' social and physical health
Symptom relief OngoingRecent Veterans of the Afghanistan and Iraq conflicts are presenting in VA care with high rates of posttraumatic stress disorder (PTSD), depression, anxiety, and substance use disorders. Difficulties with social relationships and community reintegration are common functional impa…
Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New PET scan tracer could shine a light on hidden pancreatic tumors
Diagnosis CompletedThe goal of this observational study is to evaluate the diagnostic value of ¹⁸F-Exendin-4 PET/CT imaging in renal insulinoma. Participants will undergo clinical evaluation and ¹⁸F-Exendin-4 PET/CT examination.
Sponsor: Sichuan Provincial People's Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:11 UTC